Journal
BIOLOGICAL CHEMISTRY
Volume 396, Issue 1, Pages 71-80Publisher
WALTER DE GRUYTER GMBH
DOI: 10.1515/hsz-2014-0172
Keywords
asparaginyl endopeptidase (AEP); atorvastatin; cathepsin B; legumain; macrophage; monocyte
Categories
Funding
- University of Oslo
- Anders Jahres foundation for the Promotion of Science
- Astrid and Birger Torsteds Foundation
Ask authors/readers for more resources
Macrophages express several lysosomal cysteine proteases such as cathepsins and legumain. In this study, we assessed the expression, activity and secretion of legumain in cellular models of monocytes/macrophages. Macrophages were derived from M-CSF-or GM-CSF/IFN gamma-stimulated human primary monocytes (M2 and M1, respectively), PMA-treated human THP-1 cells, or murine RAW264.7 macrophages. In both primary monocytes and THP-1 cells, monocyte-to-macrophage differentiation caused highly increased cellular expression and activity of legumain. Also, secretion of legumain from macrophages, but not from monocytes, was observed. Notably, M2 macrophages expressed significantly higher levels of active legumain than M1 macrophages, which are not previously reported. Legumain mRNA has been shown to be down-regulated in monocytes isolated from patients treated with the HMG-CoA reductase inhibitor atorvastatin. Interestingly, in our study, the active legumain produced by M2 macrophages was found to be inhibited by atorvastatin, which was reflected in aberrant cellular expression and processing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available